Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
Code effective Jul 01, 2003
HCPCS Section
Commercial Payers (Temporary Codes)
S3844 is a valid 2026 HCPCS code meaning Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness or (Dna analysis deafness) for short. HCPCS S3844 has been effective since 07/01/2003 and applies to Other medical items or services.
|
HCPCS Level II Code Section S - Commercial Payers (Temporary Codes) |
|
| HCPCS Code | S3844 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
|
| Multiple pricing indicator |
9 - Not applicable as HCPCS not priced separately by part B or value is not established
|
| Coverage code | I - Not payable by Medicare |
| BETOS2 code | Z2 - Undefined codes |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 9 - Other medical items or services |
| Effective date | Effective Jul 01, 2003 |
| Date added | Added Jul 01, 2003 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.